Aortic Valvular Stenosis
Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
Aortic stenosis (AS) is a narrowing of the aortic valve area causing obstruction to left ventricular (LV) outflow. The disease has a long asymptomatic latency period, but development of severe obstruction or onset of symptoms such as syncope, angina, and congestive heart failure (CHF) are associated with a high mortality rate without surgical intervention.
- Most common cause of LV outflow obstruction in both children and adults
- Predominant age
- <30 years: congenital
- 30 to 65 years: congenital or rheumatic fever (RF)
- >65 years: degenerative calcification of aortic valve
Etiology and Pathophysiology
- Progressive aortic leaflet thickening and calcification results in LV outflow obstruction. Obstruction causes increased afterload and, over time, decreased cardiac output.
- Increase in LV systolic pressure is required to preserve cardiac output; this leads to development of concentric LV hypertrophy (LVH). The compensatory LVH preserves ejection fraction but adversely affects heart functioning.
- LVH impairs coronary blood flow during diastole by compression of coronary arteries and reduced capillary ingrowth into hypertrophied muscle.
- LVH results in diastolic dysfunction by reducing ventricular compliance.
- Diastolic dysfunction necessitates stronger left atrial (LA) contraction to augment preload and maintain stroke volume. Loss of LA contraction by atrial fibrillation can induce acute deterioration.
- Diastolic dysfunction may persist after relief of AS due to the presence of interstitial fibrosis.
- Angina: increased myocardial demand due to higher LV pressure. Myocardial supply is compromised due to LVH.
- Syncope (exertional): can be multifactorial from inability to augment cardiac output due to the fixed obstruction to LV outflow; arrhythmias; or most commonly, abnormal baroreceptor response resulting in failure to appropriately augment blood pressure
- Heart failure: Eventually, LVH cannot compensate for increasing afterload resulting in high LV pressure and volume, which are accompanied by an increase in LA and pulmonary pressures.
- Degenerative calcific changes to aortic valve (2)
- Mechanism involves mechanical stress to valve leaflets as well as atherosclerotic changes to the valve tissue. Bicuspid valves are at higher risk for mechanical stress.
- Early lesions: subendothelial accumulation of oxidized LDL and macrophages and T lymphocytes (inflammatory response)
- Disease progression: Fibroblasts undergo transformation into osteoblasts; protein production of osteopontin, osteocalcin, and bone morphogenic protein-2 (BMP-2), which modulates calcification of leaflets
- Congenital: unicuspid valve, bicuspid valve, tricuspid valve with fusion of commissures, hypoplastic annulus
- RF: chronic scarring with fusion of commissures
- Congenital unicommissural valve or bicuspid valve (1)
- Unicommissural valve: Most cases were detected during childhood.
- Bicuspid valve: predisposes to the development of AS earlier in adulthood (4th to 5th decade) compared to tricuspid valve (6th to 8th decade)
- RF (1)
- Prevalence of chronic rheumatic valvular disease has declined significantly in the United States.
- Most cases are associated with mitral valve disease.
- Degenerative calcific changes
- Most common cause of acquired AS in the United States
- Risk factors are similar to that of coronary artery disease (CAD) and include the following: hypercholesterolemia, hypertension, smoking, male gender, age, and diabetes mellitus.
Commonly Associated Conditions
- CAD (50% of patients)
- Hypertension (40% of patients): results in “double-loaded” left ventricle (dual source of increased afterload as a result of obstruction from AS and hypertension)
- Aortic insufficiency (common in calcified bicuspid valves and rheumatic disease)
- Mitral valve disease: 95% of patients with AS from RF also have mitral valve disease.
- LV dysfunction and CHF
- Acquired von Willebrand disease: Impaired platelet function and decreased vWF results in bleeding (ecchymosis and epistaxis) in 20% of AS patients. Severity of coagulopathy is directly related to severity of AS.
- Gastrointestinal arteriovenous malformations (AVMs)
- Cerebral or systemic embolic events due to calcium emboli